Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Onapristone

    Client Email Product
    Renejix: CDMO with expertise in small molecule oral dosage, delivery tech, and multi-modality manufacturing.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Ribobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Onapristone

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Context Therapeutics® & Wisconsin Oncology Network Announce 1st Patient PhTrial
    Context Therapeutics® & Wisconsin Oncology Network Announce 1st Patient PhTrial

    27 Oct 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/10/27/2321601/0/en/Context-Therapeutics-and-Wisconsin-Oncology-Network-Announce-First-Patient-Dosed-in-Phase-2-Trial-of-ONA-XR-in-Metastatic-Breast-Cancer.html

    GLOBENEWSWIRE
    27 Oct 2021
    Share Share
    Context & Tyligand Bioscience Reach ONA-XR Manufacturing Optimization Milestone
    Context & Tyligand Bioscience Reach ONA-XR Manufacturing Optimization Milestone

    25 Aug 2021

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2021/08/25/2286290/0/en/Context-Therapeutics-and-Tyligand-Bioscience-Reach-ONA-XR-Manufacturing-Optimization-Milestone.html

    GLOBENEWSWIRE
    25 Aug 2021
    Share Share
    Context, Jefferson to Evaluate Apristor Combination for adv. Endometrial Cancer
    Context, Jefferson to Evaluate Apristor Combination for adv. Endometrial Cancer

    19 Sep 2019

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20190919005028/en

    BUSINESSWIRE
    19 Sep 2019
    Share Share
    Context & World-Renowned Cancer Center Announce a Ph2 Trial for Apristor®
    Context & World-Renowned Cancer Center Announce a Ph2 Trial for Apristor®

    02 May 2019

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20190502005076/en/Context-Therapeutics-World-Renowned-Cancer-Center-Announce-Phase/?feedref=JjAwJuNHiystnCoBq_hl-bQQCakZDujohEJegUyaJwquReQ0P23MrIoWkrUSV24ZevRMp3sIgu8q3wq1OF24lT93qbEzrwa15HGbLqMObxbNWfZlBntHS6jpH5ROLXsTFMkl05DM8ABqeyBleEmzJA==

    BUSINESSWIRE
    02 May 2019
    Share Share
    Arno Therapeutics Is Shuttering Its Doors
    Arno Therapeutics Is Shuttering Its Doors

    22 Dec 2017

    // Mark Terry BIOSPACE

    https://www.biospace.com/article/unique-arno-therapeutics-to-shut-down/

    Mark Terry BIOSPACE
    22 Dec 2017
    Share Share